Clinical trials are evolving to become more inclusive and efficient. Adaptive trial designs, which allow for modifications based on interim results, are becoming more common. This flexibility can lead to faster approval of effective treatments. Furthermore, there is a growing emphasis on patient-centered trials that prioritize the needs and preferences of participants. Efforts are also being made to increase diversity in clinical trials to ensure that findings are applicable to a broader population.
